Table 2. Characteristics of the patient cohort.
| Characteristics | Values |
|---|---|
| Age, median [range] (years) | 66 [45–86] |
| Gender, N | |
| Male | 99 |
| Female | 25 |
| Current alcohol use, N | |
| Yes | 19 |
| No | 105 |
| Hepatitis B infection, N | |
| Yes | 8 |
| No | 116 |
| Hepatitis C infection, N | |
| Yes | 56 |
| No | 68 |
| Non-alcoholic steatohepatitis, N | |
| Yes | 7 |
| No | 117 |
| Newly diagnosed, N | |
| Yes | 28 |
| No | 96 |
| Extrahepatic disease, N | |
| Yes | 8 |
| No | 116 |
| Prior targeted therapy, N | |
| Yes | 22 |
| No | 102 |
| Prior surgery, N | |
| Yes | 12 |
| No | 112 |
| Prior radiofrequency ablation, N | |
| Yes | 11 |
| No | 113 |
| Prior external beam radiotherapy, N | |
| Yes | 1 |
| No | 123 |
| Prior chemoembolization, N | |
| Yes | 18 |
| No | 106 |
| Prior radioembolization, N | |
| Yes | 30 |
| No | 94 |
| Treatment volume, N | |
| Lobar | 87 |
| Segmental | 37 |
| Median dose received, median (range) (Gy) | 131.0 (99.0–777.0) |
| Medium volume treated, median (range) (mL) | 820.0 (50.0–2,630.0) |
| Child-Pugh class | |
| A | 108 |
| B | 14 |
| C | 2 |
| ALBI grade | |
| 1 | 50 |
| 2 | 71 |
| 3 | 3 |
ALBI, Albumin-Bilirubin.